3D Printed Treatment Options | The CheckRare Brief by CheckRare Staff| Published on: Nov 4, 2026

3D Printed Treatment Options | The CheckRare Brief by CheckRare Staff| Published on: Nov 4, 2026 In this episode, we discuss a new formulation of treatment for HAE, the FDA approval of Voceryq for recurrent respiratory papillomatosis, and 3D printed treatment options. https://checkrare.com/3d-printed-treatment-options-the-checkrare-brief/

A Family’s Journey with Prader-Willi Syndrome by Chad Birt| Published on: Nov 5, 2026

A Family’s Journey with Prader-Willi Syndrome by Chad Birt| Published on: Nov 5, 2026 Maria Picone, co-founder and CEO of the TREND Community, and mother of a 14-year-old with Prader-Willi syndrome (PWS), discusses her family’s journey with PWS, including why more research and better data are so important. https://checkrare.com/a-familys-journey-with-prader-willi-syndrome/

C3G and the Pediatric VALIANT Study Bradley Dixon, MD

https://checkrare.com/c3g-and-the-pediatric-valiant-study/ C3G and the Pediatric VALIANT Study Bradley Dixon, MD Bradley Dixon, MD, a pediatric nephrologist, and Chief of Pediatric Nephrology, Children’s Hospital of Colorado, and Professor of Pediatrics, University of Colorado School of Medicine, discusses complement 3 glomerulopathy (C3G) and the pediatric VALIANT study.

Most Read Cancer Science & Oncogenesis (+...)

https://read.qxmd.com/collection/1133?ecd=wnl_readmost_261106

Climate change and health: 10 years on, what next? The Lancet (+...)

Climate change and health: 10 years on, what next? The Lancet https://www.thelancet.com/journals/lancet/issue/vol408no10567/PIIS0140-6736(26)X2042-6 The Paris Agreement came into force in 2016, a watershed in collective international action on climate change. That year also saw the creation of the Lancet Countdown on health and climate change, established to track the health effects of climate change and climate action. The past 10 years may have brought disheartening setbacks in climate policy, but there have also been huge advances in the understanding of and attitudes towards climate change. Health has become a key aspect of climate policy. COP28 had the first official Health Day, elevating health in climate negotiations, and climate laws referencing health rose sharply after 2016. The Countdown has helped to drive that change, growing into a network of regional centres across Africa, Asia, Europe, Latin America, Oceania, and Small Island Developing States that produces locally relevant indicators and evidence that have shaped policy and held governments to account. Advances in science have better illuminated the relationships between climate and health, including the adverse impacts of heat, drought, extreme rainfall, and infectious diseases such as dengue and cholera.

Amyloid fibrils help deliver RNA into sperm and embryos Often associated with neurodegenerative disease, amyloid fibrils may also help transport genetic material during fertilization. Written byBree Foster, PhD

Amyloid fibrils help deliver RNA into sperm and embryos Often associated with neurodegenerative disease, amyloid fibrils may also help transport genetic material during fertilization. Written byBree Foster, PhD https://www.drugdiscoverynews.com/amyloid-fibrils-help-deliver-rna-into-sperm-and-embryos-17629 Amyloid fibrils — protein structures commonly associated with neurodegenerative diseases such as Alzheimer's and Parkinson's — may have an unexpected role in reproduction, according to a study recently published in Molecular Cell. Researchers at Columbia University's Zuckerman Institute found that amyloid fibrils in seminal fluid can bind RNA and help transport it into sperm and embryos. The findings suggest these structures may have a previously unrecognized role in transferring genetic material during fertilization, while also raising questions about whether their properties could eventually be harnessed to deliver RNA-based therapeutics or components of gene-editing technologies such as CRISPR.

New wave of health and STEM candidates could reshape US science policy A massive cancer drug deal, a new license for gut-targeted drugs, and both regulatory and company-led halts on clinical trials led the news this week. Brought to you byDDN editorial team

New wave of health and STEM candidates could reshape US science policy A massive cancer drug deal, a new license for gut-targeted drugs, and both regulatory and company-led halts on clinical trials led the news this week. Brought to you byDDN editorial team https://www.drugdiscoverynews.com/new-wave-of-health-and-stem-candidates-could-reshape-us-science-policy-17640 The election of a new wave of candidates with backgrounds in medicine, science, and engineering could have implications for US health and science policy as the country grapples with healthcare costs, research funding, and disputes over vaccines and public health. The victories included Dr Amy Acton, Ohio’s former health director who was elected governor of Ohio, Dr Abdul El-Sayed, a public health administrator who won a US Senate seat in Michigan, and Dr Jasmine Clark, a microbiologist and molecular geneticist who was elected as Congress woman of the state of Georgia. STEM professionals remain relatively rare in elected office — fewer than 10 percent of members of Congress have backgrounds in medicine, public health, or engineering — potentially giving the incoming lawmakers greater influence and expertise over debates on healthcare access, federal research funding, and public health policy at a time of major changes to the US scientific and public health infrastructure. – Bree Foster